SCHEMBL23937801

SCHEMBL23937801

CCn1cc(C2CC2)c2sccc21

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
PDE7A Q13946 4/20 0.32
PDE4B Q07343 2/20 0.31
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20631027 0.75 FEN1 (0.30)
SCHEMBL23937805 0.74 KMT2A (0.35) KMT2APDE7APDE4B
SCHEMBL20673887 0.71 KMT2A (0.33) KMT2APDE7A
SCHEMBL20674234 0.69 KMT2A (0.32) KMT2A
SCHEMBL23937800 0.68 NR4A2 (0.40) KMT2AMEN1
SCHEMBL20673904 0.67 MAP2K2 (0.41) KMT2AMEN1
SCHEMBL20674231 0.65 LMNA (0.43) KMT2AMEN1
SCHEMBL22383810 0.61 SLC6A4 (0.48) KMT2AMEN1
SCHEMBL12213145 0.59
SCHEMBL14985269 0.59 KDM1A (0.34) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed